Home Services PRisMA 2024 ISO 45003 Training Resources Blog About Book Appt Contact

Overview

What Is Heavy Metal Surveillance?

Heavy metal medical surveillance is a systematic programme of biological monitoring and clinical assessment designed to detect early signs of excessive exposure to toxic metals in the workplace. Unlike environmental monitoring, which measures airborne concentrations, biological monitoring directly measures the amount of a substance or its metabolites in a worker's blood, urine, or other biological specimens — providing a true picture of the dose absorbed by the body through all routes of exposure, including inhalation, skin absorption, and ingestion.

Heavy metals such as mercury, cadmium, chromium, arsenic, and manganese are widely used in Malaysian industries. Chronic exposure to these substances, even at levels below immediately noticeable symptoms, can lead to irreversible damage to the kidneys, lungs, nervous system, and other organs. A structured surveillance programme enables early detection and intervention before clinical disease develops, protecting your workers and fulfilling your legal obligations under Malaysian occupational health law.

Who Needs This

Industries at Risk of Heavy Metal Exposure

Workers in the following sectors may be routinely exposed to hazardous metals and require structured biological monitoring as part of their medical surveillance programme.

Electroplating & Metal Finishing
Welding & Fabrication
Semiconductor Manufacturing
Chemical Manufacturing
Battery Production
Smelting & Foundries
Paint & Pigment Manufacturing
Rubber & Plastics Industry
Glass Manufacturing
Electronics Assembly
Mining & Ore Processing
Dental Laboratories
Pesticide Production
Jewellery Manufacturing
Waste Treatment & Recycling
Laboratory & Research Facilities

Biological Monitoring

Metals Covered & Monitoring Tests

Each heavy metal requires specific biological specimens and analytical methods. The following cards outline the key metals monitored, the biological tests used, and the specimen types collected during surveillance.

Hg

Mercury

Biological monitoring for mercury exposure uses urine mercury (spot or 24-hour collection) as the primary biomarker, reflecting recent and chronic exposure to inorganic mercury vapour. Blood mercury may also be measured for organic mercury (methylmercury) exposure. The BEI (Biological Exposure Index) is referenced against ACGIH and DOSH guidelines.

Urine Mercury · Blood Mercury

Cd

Cadmium

Urine cadmium reflects cumulative body burden and is the preferred biomarker for long-term exposure assessment. Blood cadmium indicates more recent exposure. Both tests are critical for workers in battery manufacturing, electroplating, and smelting, where cadmium fumes and dust are common hazards.

Urine Cadmium · Blood Cadmium

Cr

Chromium

Hexavalent chromium (Cr VI) is a known carcinogen. Biological monitoring primarily uses urine chromium collected at end-of-shift and end-of-work-week. Blood chromium may complement assessment. Workers in electroplating, stainless steel welding, and chrome pigment manufacturing are at particular risk.

Urine Chromium · Blood Chromium

As

Arsenic

Urine arsenic (speciated) is the primary biomarker, distinguishing inorganic arsenic and its metabolites from non-toxic organic forms found in seafood. Speciated urine arsenic should be collected at end-of-work-week. Workers in semiconductor fabrication, pesticide production, and glass manufacturing are commonly monitored.

Speciated Urine Arsenic

Mn

Manganese

Blood manganese and urine manganese serve as biomarkers, though correlation with exposure levels can be variable. Clinical assessment for early neurological signs (manganism) is an essential component of surveillance. Welders and workers in steel manufacturing and dry-cell battery production are at greatest risk.

Blood Manganese · Urine Manganese

Ni

Nickel

Urine nickel is the standard biomarker for monitoring occupational exposure to soluble nickel compounds. Sampling is typically performed at end-of-shift. Nickel exposure occurs in electroplating, stainless steel production, nickel refining, and welding of nickel alloys. Inhalation of certain nickel compounds is associated with respiratory cancers.

Urine Nickel

Co

Cobalt

Urine cobalt and blood cobalt are used to assess occupational exposure. End-of-shift urine samples best reflect recent exposure. Cobalt is encountered in hard metal (tungsten carbide) manufacturing, diamond polishing, and ceramic pigment production. Hard metal lung disease is a recognised occupational condition.

Urine Cobalt · Blood Cobalt

Be

Beryllium

Urine beryllium provides exposure data, while the Beryllium Lymphocyte Proliferation Test (BeLPT) is used for sensitisation screening. Workers in aerospace, ceramics, electronics, and nuclear industries may be exposed. Chronic beryllium disease (berylliosis) is a serious granulomatous lung condition requiring early detection.

Urine Beryllium · BeLPT

How It Works

The Surveillance Process

A structured medical surveillance programme for heavy metal exposure follows a systematic approach, ensuring that workers are assessed before exposure begins, monitored at regular intervals, and managed appropriately when abnormal results are detected.

01

Baseline Assessment

Before a worker begins employment in a role involving heavy metal exposure, a baseline health assessment is conducted. This includes a comprehensive occupational history, targeted physical examination, and collection of baseline biological specimens (blood and/or urine). These baseline values serve as a reference point for all future monitoring.

02

Periodic Monitoring

Workers undergo biological monitoring at regular intervals determined by the type of metal, exposure level, and regulatory requirements. Typically this ranges from every three to twelve months. Specimens are collected under standardised conditions (e.g., end-of-shift, end-of-work-week) to ensure accuracy and comparability.

03

Biological Exposure Indices

Results are compared against established Biological Exposure Indices (BEIs) set by the ACGIH, as well as permissible exposure limits referenced by DOSH Malaysia. These thresholds indicate the level below which nearly all workers should not experience adverse health effects from the corresponding chemical exposure.

04

Clinical Evaluation

Where biological monitoring results approach or exceed the BEI, or when a worker reports symptoms, a detailed clinical evaluation is performed. This may include targeted organ-specific assessments such as renal function panels, neurological examination, pulmonary function testing, or dermatological assessment, depending on the metal involved.

05

Reporting & Notification

Results are reported to the employer (with appropriate confidentiality) and, where required by law, to DOSH. If a worker is found to have occupational poisoning or disease, the OHD completes the mandatory notification to the Director General of DOSH using the prescribed forms under the Occupational Safety and Health Act 1994.

06

Follow-Up & Corrective Action

Abnormal results trigger a management pathway: repeat testing, temporary removal from exposure, referral to a specialist, and review of workplace controls. The OHD works with the employer to implement corrective measures such as improved ventilation, PPE upgrades, or process changes to reduce exposure at the source.

Legal Framework

Malaysian Regulatory Requirements

Employers in Malaysia who use chemicals hazardous to health, including heavy metals, are subject to specific legal obligations under the Occupational Safety and Health Act 1994 and its subsidiary legislation. Failure to comply can result in enforcement action, fines, and criminal liability.

USECHH Regulations 2000

The Use and Standards of Exposure of Chemicals Hazardous to Health (USECHH) Regulations 2000 require employers to:

  • Conduct a Chemical Health Risk Assessment (CHRA) for all processes involving chemicals hazardous to health
  • Appoint a registered Occupational Health Doctor (OHD) to carry out medical surveillance for workers exposed to scheduled chemicals
  • Provide medical surveillance at prescribed intervals as determined by the OHD based on the nature and level of exposure
  • Maintain records of all medical surveillance results for a minimum of 30 years
  • Notify DOSH of any occupational poisoning or disease detected through surveillance

Permissible Exposure Limits (PELs)

DOSH Malaysia prescribes Permissible Exposure Limits for airborne concentrations of heavy metals in the workplace. These include Time-Weighted Average (TWA) limits for 8-hour exposures and Short-Term Exposure Limits (STELs) for 15-minute periods. The OHD uses both environmental monitoring data and biological monitoring results to assess whether worker exposures are adequately controlled.

OHD Responsibilities

The registered Occupational Health Doctor bears specific statutory responsibilities in heavy metal surveillance programmes:

  • Determining the type, frequency, and scope of biological monitoring based on the CHRA findings
  • Interpreting results against BEIs and advising employers on fitness-for-work and exposure control measures
  • Issuing medical removal recommendations when a worker's results exceed action levels
  • Completing statutory notification forms for cases of occupational poisoning (e.g., mercurialism, cadmium poisoning)
  • Advising on the adequacy of engineering controls, administrative controls, and personal protective equipment

Why It Matters

Health Effects of Heavy Metal Exposure

Each heavy metal targets specific organ systems. Chronic low-level exposure often produces insidious damage that is irreversible once clinically apparent. Early detection through biological monitoring is the most effective strategy for preventing occupational disease.

Mercury

Chronic inorganic mercury exposure causes tremor, erethism (irritability, memory loss, insomnia), gingivitis, and renal tubular damage. Severe cases progress to personality changes, hallucinations, and permanent neurological impairment. Organic mercury (methylmercury) primarily affects the central nervous system.

Cadmium

Cadmium accumulates in the kidneys with a biological half-life of 10 to 30 years. Chronic exposure leads to renal tubular dysfunction, characterised by low molecular weight proteinuria, and osteoporosis/osteomalacia. Cadmium is classified as a Group 1 carcinogen (IARC), with established links to lung cancer.

Chromium (Hexavalent)

Hexavalent chromium (Cr VI) is a potent respiratory carcinogen (Group 1, IARC) associated with lung cancer and sinonasal cancer. It also causes allergic contact dermatitis, nasal septum perforation, and occupational asthma. Chrome ulcers on the skin are a hallmark of direct contact exposure.

Arsenic

Chronic inorganic arsenic exposure causes peripheral neuropathy, skin changes (hyperpigmentation, keratoses), vascular disease, and cancers of the lung, skin, and bladder. Arsenic is a Group 1 carcinogen. Early signs include skin lesions and peripheral numbness that may be mistaken for other conditions.

Manganese

Chronic manganese inhalation causes manganism, a progressive neurological syndrome resembling Parkinson's disease, with symptoms including tremor, gait disturbance, mood changes, and cognitive impairment. Early psychiatric symptoms (irritability, compulsive behaviour) may precede motor deficits by months or years.

Nickel

Inhalation of nickel compounds, particularly nickel subsulfide and nickel oxide, is associated with lung cancer and nasal sinus cancer. Nickel is also one of the most common causes of allergic contact dermatitis (nickel itch). Occupational asthma from nickel exposure has been documented in electroplating workers.

Cobalt

Cobalt exposure causes hard metal lung disease (giant cell interstitial pneumonitis), occupational asthma, and allergic contact dermatitis. High exposure may also result in cardiomyopathy and thyroid dysfunction. Workers grinding or machining tungsten carbide tools are at highest risk.

Beryllium

Beryllium causes chronic beryllium disease (CBD), a granulomatous lung condition that can develop years after initial sensitisation. Acute high-dose exposure can cause chemical pneumonitis. Beryllium is classified as a Group 1 carcinogen. The BeLPT screening test identifies sensitised workers before lung disease develops.

Business Case

Benefits to Employers

A well-implemented heavy metal surveillance programme is not merely a regulatory requirement — it delivers measurable value to your organisation by protecting your workforce, reducing liability, and demonstrating your commitment to occupational health excellence.

  • Regulatory Compliance Meet all statutory obligations under USECHH 2000, OSHA 1994, and related DOSH requirements, avoiding enforcement action and penalties.
  • Early Detection & Prevention Identify excessive exposures before clinical disease develops, enabling timely intervention and preventing irreversible health damage in your workforce.
  • Reduced Liability Documented surveillance records demonstrate due diligence and provide legal protection in the event of occupational disease claims or DOSH investigations.
  • Improved Workplace Controls Surveillance data provides objective evidence of the effectiveness of engineering controls, helping you target investments in ventilation, process changes, and PPE where they matter most.
  • Worker Confidence & Retention Employees who know their health is being actively monitored are more engaged, more productive, and more likely to remain with the organisation.
  • SOCSO & Insurance Optimisation Proactive health monitoring supports SOCSO claims management and may contribute to more favourable insurance terms by demonstrating robust risk management practices.

Ensure your workers are protected from heavy metal exposure

Get in Touch →